论文部分内容阅读
迄今大多数(90%)支气管肺癌病人尚不能治愈。为延长存活期,提高存活质量,常需对肿瘤产生的症状进行姑息治疗。体外照射是一种主要的姑息疗法,但常因病变周围正常组织不能耐受而使其剂量受限。此外,对某些症状的改善也不理想。在1937年,Ormerod 第一次报告应用硬质支气管镜植入氡小管治疗支气管肺癌获得成功。现在作者对该项技术进行改革,应用纤维支气管镜植入
To date, most (90%) patients with bronchial lung cancer have not been cured. In order to prolong survival and improve the quality of life, it is often necessary to palliatively treat the symptoms of the tumor. External irradiation is a major palliative treatment, but its dose is often limited by the inability of normal tissue around the lesion. In addition, the improvement of some symptoms is not ideal. In 1937, Ormerod reported for the first time the use of hard bronchoscopically implanted fistulas for the treatment of bronchial lung cancer. The authors now reform the technology and apply fiberoptic bronchoscope implantation